Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Last Updated
Federal Trade Commission, Plaintiff, v. Regenerative Medical Group, Inc., a corporation; Telehealth Medical Group, INC., a corporation; and Bryn Jarald Henderson, D.O., individually and as an officer of Regenerative Medical Group, Inc. and Telehealth Medical Group, Inc., Defendants.
FTC Matter/File Number
172 3062
Civil Action Number
8:18-cv-01838-AG-KES
Enforcement Type
Federal Injunctions
Federal Court
Central District of California

Case Summary

The FTC is mailing 270 checks totaling nearly $515,000 to consumers who paid for what the agency alleged was deceptively advertised “amniotic stem cell therapy” between 2014 and 2017. The average amount each consumer will receive is $1,907.